These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37614579)

  • 1. Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and Heart Failure.
    van den Berg PF; Aboumsallem JP; Screever EM; Shi C; de Wit S; Bracun V; Yousif LI; Geerlings L; Wang D; Ho JE; Bakker SJL; van der Vegt B; Silljé HHW; de Boer RA; Meijers WC
    JACC CardioOncol; 2023 Aug; 5(4):445-453. PubMed ID: 37614579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function largely influences Galectin-3 prognostic value in heart failure.
    Zamora E; Lupón J; de Antonio M; Galán A; Domingo M; Urrutia A; Troya M; Bayes-Genis A
    Int J Cardiol; 2014 Nov; 177(1):171-7. PubMed ID: 25499371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin 3: association to neurohumoral activity, echocardiographic parameters and renal function in outpatients with heart failure.
    Stoltze Gaborit F; Bosselmann H; Kistorp C; Iversen K; Kumler T; Gustafsson F; Goetze JP; Sölétormos G; Tønder N; Schou M
    BMC Cardiovasc Disord; 2016 May; 16():117. PubMed ID: 27246703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin and galectin-3 predict the risk of ventricular tachycardia and fibrillation in heart failure patients with implantable defibrillators.
    Francia P; Adduci C; Semprini L; Borro M; Ricotta A; Sensini I; Santini D; Caprinozzi M; Balla C; Simmaco M; Volpe M
    J Cardiovasc Electrophysiol; 2014 Jun; 25(6):609-16. PubMed ID: 24400815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma galectin 3 and heart failure risk in the Physicians' Health Study.
    Djoussé L; Matsumoto C; Petrone A; Weir NL; Tsai MY; Gaziano JM
    Eur J Heart Fail; 2014 Mar; 16(3):350-4. PubMed ID: 24464746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin 3 and incident atrial fibrillation in the community.
    Ho JE; Yin X; Levy D; Vasan RS; Magnani JW; Ellinor PT; McManus DD; Lubitz SA; Larson MG; Benjamin EJ
    Am Heart J; 2014 May; 167(5):729-34.e1. PubMed ID: 24766984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating systemic fibrosis by combining galectin-3 and ST2 provides powerful risk stratification value for patients after acute decompensated heart failure.
    Wang CH; Yang NI; Liu MH; Hsu KH; Kuo LT
    Cardiol J; 2016; 23(5):563-572. PubMed ID: 27515479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure.
    Caravaca Perez P; González-Juanatey JR; Nuche J; Matute-Blanco L; Serrano I; Martínez Selles M; Vázquez García R; Martínez Dolz L; Gómez-Bueno M; Pascual Figal D; Crespo-Leiro MG; García-Osuna Á; Ordoñez-Llanos J; Cinca Cuscullola J; Guerra JM; Delgado JF
    Front Cardiovasc Med; 2022; 9():861651. PubMed ID: 35463785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic profile provides prognostic value better than galectin-3 in patients with heart failure.
    Wang CH; Cheng ML; Liu MH; Kuo LT; Shiao MS
    J Cardiol; 2017 Jul; 70(1):92-98. PubMed ID: 28318874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study.
    Asleh R; Enriquez-Sarano M; Jaffe AS; Manemann SM; Weston SA; Jiang R; Roger VL
    J Am Coll Cardiol; 2019 May; 73(18):2286-2295. PubMed ID: 31072572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of moderately reduced renal function on the diagnostic and prognostic value of galectin-3 in patients with exertional dyspnea.
    Karolko B; Serafin A; Przewłocka-Kosmala M
    Adv Clin Exp Med; 2022 Aug; 31(8):873-879. PubMed ID: 35467088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial galectin-3 and future cardiovascular disease in the general population.
    van der Velde AR; Meijers WC; Ho JE; Brouwers FP; Rienstra M; Bakker SJ; Muller Kobold AC; van Veldhuisen DJ; van Gilst WH; van der Harst P; de Boer RA
    Heart; 2016 Jul; 102(14):1134-41. PubMed ID: 27084804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure.
    Lok DJ; Lok SI; Bruggink-André de la Porte PW; Badings E; Lipsic E; van Wijngaarden J; de Boer RA; van Veldhuisen DJ; van der Meer P
    Clin Res Cardiol; 2013 Feb; 102(2):103-10. PubMed ID: 22886030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
    Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
    Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-3 is linked to peripheral artery disease severity, and urinary excretion is associated with long-term mortality.
    Ursli M; Zierfuss B; Grigassy T; Pesau G; Koppensteiner R; Schernthaner GH; Höbaus C
    Atherosclerosis; 2022 Jan; 341():7-12. PubMed ID: 34929561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-3 and fibulin-1 in systolic heart failure - relation to glucose metabolism and left ventricular contractile reserve.
    Holmager P; Egstrup M; Gustafsson I; Schou M; Dahl JS; Rasmussen LM; Møller JE; Tuxen C; Faber J; Kistorp C
    BMC Cardiovasc Disord; 2017 Jan; 17(1):22. PubMed ID: 28068900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure and the prognostic impact and incidence of new-onset of diabetes mellitus: a nationwide cohort study.
    Zareini B; Rørth R; Holt A; Mogensen UM; Selmer C; Gislason G; Schou M; Køber L; Torp-Pedersen C; Lamberts M; Kristensen SL
    Cardiovasc Diabetol; 2019 Jun; 18(1):79. PubMed ID: 31189473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3 in Patients with Acute Heart Failure: Preliminary Report on First Polish Experience.
    Sygitowicz G; Tomaniak M; Filipiak KJ; Kołtowski Ł; Sitkiewicz D
    Adv Clin Exp Med; 2016; 25(4):617-23. PubMed ID: 27629834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Galectin-3 Levels Are Persistently Elevated After Heart Transplantation and Are Associated With Renal Dysfunction.
    Grupper A; Nativi-Nicolau J; Maleszewski JJ; Geske JR; Kremers WK; Edwards BS; Kushwaha SS; Pereira NL
    JACC Heart Fail; 2016 Nov; 4(11):847-856. PubMed ID: 27614937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.